tiprankstipranks
Trending News
More News >
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH

Aurinia Pharmaceuticals (AUPH) Revenue

Compare
2,029 Followers

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had a revenue of 59.87M in the quarter ending Dec 31, 2024, with -11.66%. This bring the company's revenue in the last twelve months to 235.13M, Decreased 6.70%. In the fiscal year ending Dec 31, 2024, Aurinia Pharmaceuticals had annual revenue of 235.13M with 33.97% growth.
Revenue (ttm)
235.13M
Revenue Growth
29.20%
P/S Ratio
4.75
Revenue/Employee
$1,808,715
Employees
130
Market Cap
$1.12B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
235.13M59.62M+33.97%
Dec 31, 2023
175.51M41.48M+30.95%
Dec 31, 2022
134.03M88.42M+193.89%
Dec 31, 2021
45.60M-4.51M-9.00%
Dec 31, 2020
50.12M49.80M+15,660.38%
Dec 31, 2019
318.00K-145.00K-31.32%
Dec 31, 2018
463.00K43.00K+10.24%
Dec 31, 2017
420.00K247.00K+142.77%
Dec 31, 2016
173.00K-62.00K-26.38%
Dec 31, 2015
235.00K-43.00K-15.47%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis